AI assistant
Supriya Lifescience Limited — Call Transcript 2023
Oct 27, 2023
59375_rns_2023-10-27_82194433-fe8d-4652-bed5-4a2f9766a195.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [426 x 68] intentionally omitted <==
Date: October 27, 2023
To,
The Corporate Services Department, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001 Scrip Code: 543434
Manager - Listing Department The National Stock Exchange of India Ltd. Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex Bandra (E), Mumbai - 400 051 NSE Symbol: SUPRIYA
Dear Sir/Madam,
Subject: Intimation of Earnings Call for Q2 & H1 of FY 2023-24
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that an earnings call will be held on Wednesday, November 8, 2023 at 11.00 A.M. IST to discuss operational and financial performance of the Company for the quarter and half year ended September 30, 2023 (Q2 & H1 of FY 2023-24). The invite giving requisite details including the pre-registration link and dial-in details is attached herewith.
This intimation is also being made available on the website of the Company at: https://supriyalifescience.com/investor-relation/
Kindly take the information on record.
Thanking you,
For Supriya Lifescience Limited
SHWETA Digitally signed by SHWETA SHIVDHARI SHIVDHARI SINGH Date: 2023.10.27 12:26:34 SINGH +05'30' Shweta Singh Company Secretary & Compliance Officer Membership No.: A44973
Corporate office : 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063. Maharashtra, India. Tel: +91 22 40332727 / 66942507 Fax : +91 22 26860011 GSTIN: 27AALCS8686A1ZX CIN: L51900MH2008PLC180452 E-mail: supriya@supriyalifescience .com Website: www.supriyalifescience.com
Factory : A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India. Tel: +91 2356 272299 Fax: +91 2356 272178 E-mail: [email protected]
GOVT. RECOGNISED EXPORT HOUSE
Supriya Lifescience Ltd
Cordially Invites you to Earning call To discuss operational and financial performance for Q2 & H1 FY24
Wednesday, 08[th] November 2023 at 11:00 AM, IST Pre - Registration Link - Click Here
Participants
Dr. Satish Wagh - Chairman & Managing Director Dr. Saloni Wagh - Whole Time Director Mr. Krishna Raghunathan - Chief Financial Officer
Access Numbers +91 22 6280 1550 Primary Number +91 22 7115 8378 Hongkong: 800 964 448 Singapore: 800 101 2045 International Toll Free Number USA: 1 866 746 2133 UK: 0 808 101 1573
RSVP : Mr. Irfan Raeen, Orient Capital - IR
Contact / Email : +91 97737 78669/ [email protected]